Startups
Opening a 503A pharmacy and needing a path from entity setup to first dispense.
503A consulting for licensing, cleanroom buildout, USP readiness, SOPs, and operational growth.
Written consultation roadmap with owners, timelines, and risk areas.
Sterile and non-sterile compounding pharmacy advisory only.
Multi-state licensing strategy and sequencing support.
Pinnacle helps translate complex 503A requirements into operating systems your team can use and inspectors can evaluate.

Pinnacle works with pharmacy owners and operators when regulatory risk, buildout decisions, or growth plans require experienced judgment.
Opening a 503A pharmacy and needing a path from entity setup to first dispense.
Already have a location, license work, or buildout underway and need the gaps closed.
Need USP readiness, updated SOPs, mock audit support, or growth without compliance drift.
Adding states, peptides, new formulation categories, personnel, or advisory capacity.
Illustrative engagement outcomes based on the scope of work Pinnacle provides across licensing, compliance, and buildout phases.
Illustrative · Newly opened sterile pharmacy
Mock audit, EM trending corrections, and full SOP gap closure completed six weeks before the board visit.
Illustrative · Startup compounding operation
Sequenced DEA registration, state board applications, and NABP credentialing across three target states.
Illustrative · In-development 503A pharmacy
USP 795/797/800 SOPs, batch record system, and MFR templates delivered prior to opening day.
Services are organized around the points where pharmacy projects usually stall: licensing, facilities, quality systems, and growth.
For pharmacists, owners, and investors moving from concept to first dispense.
Gap analysis, SOP audit, FDA history review, facility assessment, and a written roadmap in 5 business days.
Entity guidance, DEA strategy, state board applications, NABP credentialing, PCAB planning, and multi-state sequencing.
For teams creating the physical, procedural, and quality foundation inspectors expect.
ISO classification planning, HVAC review, hood selection, workflow design, contractor coordination, and certification support.
Sterile, non-sterile, hazardous, QA, EM, MFR, batch record, training, and document-control libraries.
For active pharmacies strengthening compliance, expanding scope, and improving throughput.
USP 795/797/800 programs, EM trending, CAPA, QAPI, change control, mock audits, and inspection readiness.
Approved supplier lists, vendor qualification, incoming inspection, material specs, quarantine systems, and API review.
Clear scope, written deliverables, and direct accountability from the first call.
Your first engagement turns a messy pharmacy build into a prioritized action plan with owners, timelines, and risk areas.
Clients work through Pinnacle leadership, with one accountable point of contact and written updates throughout the project.
The advice comes from inside real compounding operations, where cleanrooms, SOPs, inspections, and batches have to hold up.
Peptide and 503A bulk-substance guidance is handled carefully as FDA review, enforcement, and list status continue to evolve.
Initial Consultation
The initial consultation maps compliance risks, facility requirements, and licensing paths before any larger scope begins.
Gap analysis
Situation review across licensing, facilities, quality systems, and SOP status.
Priority action plan
Written roadmap with owners, timelines, and ranked risk areas, in 5 business days.
Next-step scope
State board sequencing strategy and a clear path to the right engagement level.
Confidential Gap Analysis Report
Start with a focused consultation, compliance review, and written roadmap before you commit to a larger engagement.